129 related articles for article (PubMed ID: 8456068)
1. The pharmacokinetics and absorption of recombinant human relaxin in nonpregnant rabbits and rhesus monkeys after intravenous and intravaginal administration.
Chen SA; Reed B; Nguyen T; Gaylord N; Fuller GB; Mordenti J
Pharm Res; 1993 Feb; 10(2):223-7. PubMed ID: 8456068
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of recombinant human relaxin in nonpregnant women after intravenous, intravaginal, and intracervical administration.
Chen SA; Perlman AJ; Spanski N; Peterson CM; Sanders SW; Jaffe R; Martin M; Yalcinkaya T; Cefalo RC; Chescheir NC
Pharm Res; 1993 Jun; 10(6):834-8. PubMed ID: 8257492
[TBL] [Abstract][Full Text] [Related]
3. The disposition of a human relaxin (hRlx-2) in pregnant and nonpregnant rats.
Cossum PA; Dwyer KA; Roth M; Chen SA; Moffat B; Vandlen R; Ferraiolo BL
Pharm Res; 1992 Mar; 9(3):419-24. PubMed ID: 1614978
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics and metabolism of human relaxins in rhesus monkeys.
Ferraiolo BL; Winslow J; Laramee G; Celniker A; Johnston P
Pharm Res; 1991 Aug; 8(8):1032-8. PubMed ID: 1924156
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of human leptin in mice and rhesus monkeys.
Ahrén B; Baldwin RM; Havel PJ
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1579-85. PubMed ID: 11126209
[TBL] [Abstract][Full Text] [Related]
6. Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats.
Danielson LA; Conrad KP
J Appl Physiol (1985); 2003 Oct; 95(4):1509-14. PubMed ID: 12819218
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey.
Klein J; Lobel L; Pollak S; Ferin M; Xiao E; Sauer M; Lustbader JW
Fertil Steril; 2002 Jun; 77(6):1248-55. PubMed ID: 12057736
[TBL] [Abstract][Full Text] [Related]
8. Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats.
Debrah DO; Conrad KP; Jeyabalan A; Danielson LA; Shroff SG
Hypertension; 2005 Oct; 46(4):745-50. PubMed ID: 16172427
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
Patel IH; Levy RH; Bauer TG
Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of serelaxin in patients with acute or chronic heart failure, hepatic or renal impairment, or portal hypertension and in healthy subjects.
Soubret A; Pang Y; Yu J; Dahlke M
Br J Clin Pharmacol; 2018 Nov; 84(11):2572-2585. PubMed ID: 30014598
[TBL] [Abstract][Full Text] [Related]
11. Administration study of recombinant human relaxin-2 in horse for doping control purpose.
Kwok WH; Choi TLS; Leung GNW; Wong ASY; Yue SK; Wan TSM; Ho ENM
Drug Test Anal; 2020 Mar; 12(3):361-370. PubMed ID: 31726484
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys.
Guo L; Li Z; Xu B; Yu M; Fu Y; Liu L; Wang J; Luo Y
Life Sci; 2019 Dec; 238():116967. PubMed ID: 31626794
[TBL] [Abstract][Full Text] [Related]
13. Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response.
Debrah DO; Conrad KP; Danielson LA; Shroff SG
J Appl Physiol (1985); 2005 Mar; 98(3):1013-20. PubMed ID: 15489259
[TBL] [Abstract][Full Text] [Related]
14. Induction of relaxin secretion in rhesus monkeys by human chorionic gonadotropin: dependence on the age of the corpus luteum of the menstrual cycle.
Ottobre JS; Nixon WE; Stouffer RL
Biol Reprod; 1984 Dec; 31(5):1000-6. PubMed ID: 6518224
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human relaxin (rhRLX) modifies systemic arterial properties in conscious rats irrespective of gender, but in a biphasic fashion.
Debrah DO; Conrad KP; Novak J; Danielson LA; Shroff SG
Ann N Y Acad Sci; 2005 May; 1041():155-62. PubMed ID: 15956701
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration.
Ferraiolo BL; Fuller GB; Burnett B; Chan E
J Biol Response Mod; 1988 Apr; 7(2):115-22. PubMed ID: 3129541
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human relaxin as a cervical ripening agent.
Brennand JE; Calder AA; Leitch CR; Greer IA; Chou MM; MacKenzie IZ
Br J Obstet Gynaecol; 1997 Jul; 104(7):775-80. PubMed ID: 9236640
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat.
Tozzi CA; Poiani GJ; McHugh NA; Shakarjian MP; Grove BH; Samuel CS; Unemori EN; Riley DJ
Pulm Pharmacol Ther; 2005; 18(5):346-53. PubMed ID: 15939313
[TBL] [Abstract][Full Text] [Related]
19. The effect of relaxin infusion on prolactin and growth hormone secretion in monkeys.
Bethea CL; Cronin MJ; Haluska GJ; Novy MJ
J Clin Endocrinol Metab; 1989 Nov; 69(5):956-62. PubMed ID: 2793997
[TBL] [Abstract][Full Text] [Related]
20. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man.
Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN
Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
